GlassScriptPhysician profile
Bianca Green
NPI 1154872190
$1,494.50
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $109 · 2023: $42.27 · 2024: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $691 · Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $690.95 |
| Food and Beverage | $563.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,157.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $83.67 | 2022-2024 | |
| Novo Nordisk INC | $53.31 | 2021-2022 | |
| Amgen INC. | $36.57 | 2021 | |
| Medtronic, INC. | $32.34 | 2024 | Intellis Adaptivestim |
| Amarin Pharma, INC. | $31.86 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.50 | 2022 | |
| Eisai INC. | $15.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.58 | 2022 | |
| Jazz Pharmaceuticals INC. | $12.14 | 2021 | |
| Lilly USA, LLC | $11.35 | 2021 | |
| Clarus Therapeutics INC. | $9.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.